Skip to main content
. 2021 Jan 18;12(3):378–390. doi: 10.1021/acschemneuro.0c00729

Figure 3.

Figure 3

Structure of endogenous cannabinoid receptor ligands, (−)-Δ9-THC and pravalodine. (b) Structure of a selective CB2 receptor agonist (compound 1) and antagonist (compound 2) and their interactions in the CB2 binding site (Adapted with permission from ref (39). Copyright (2017) American Chemical Society.).